Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives

BACKGROUND: A core evaluation framework that captures the health care and societal benefits of value added medicines (VAMs, also often called repurposed medicines) was proposed in Report 1, aiming to reduce the heterogeneity in value assessment processes across countries and to create incentives for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaló, Zoltán, Petykó, Zsuzsanna Ida, Fricke, Frank-Ulrich, Maniadakis, Nikos, Tesař, Tomáš, Podrazilová, Kateřina, Espin, Jaime, Inotai, András
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280561/
https://www.ncbi.nlm.nih.gov/pubmed/34266465
http://dx.doi.org/10.1186/s12962-021-00296-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280561/
https://www.ncbi.nlm.nih.gov/pubmed/34266465
http://dx.doi.org/10.1186/s12962-021-00296-2

Ejemplares similares